Fibrin 용해 균주의 분리 및 특성

Isolation and Characterization of a Bacterium with a Fibrinolytic Activity

  • 정용준 (전주대학교 이공대학 생명과학부)
  • 발행 : 1999.02.01

초록

혈전 용해효소를 생산하는 미생물을 탐색하기 위하여 장류 및 토양사료로부터 미생물을 분리하여 그 중 fibrin 용해활성이 높고 기질특이성이 우수한 S7-l6 균주를 선발하였다. 선발된 미생물은 Gram 양성의 간균으로 운동성이 있고, catalase 양성이었으며 포자를 형성하는 것으로 관찰되어 BClcilius sp. S7-16으로 명명하였다. $\alpha$cill$\mu$ sp S7-16의 효소생산 조건을 검토한 결과,0.5% (w/v) polypeptone, 0.5% (w/v) yeast extract, 0.3% (w/v) NaCI, 0.l%(w/v) $KH_2P0_4$, 0.3% (w/v) $KH_2P0_4$, 0.01% (w/v) $MgSO_4.7H_20$(pH7.0)의 배지조성하에서 $35^{\circ}C$애서 180 rpm으로 24시간 회전진탕배양하였을 때 fibrin 용해효소 생산이 최대를 보였으며, 이때 casein 용해활성은 나타나지 않았다. Fibrin 용해효소의 효소적 특성을 조사하기 위해 이 조건하에서 얻어진 배양상동액에 20~60% ammomum sulfate 분획침전을 행하여 조효소액을 조제하였으며, 얻어진 조효소액은 pH4~11의 범위에서 안정하였으며, $50^{\circ}C$까지 비교적 활성이 유지되는 열안 정성을 보여주었다. 조효소액의 최적 pH와 온도는 각각 7.5, $40^{\circ}C$부근에서 최적활성을 보였다.

A bacterium having strong fibrinolytic activity, S7-16 strain, was isolated from soil. The isolated bacterium was identified and named as Bacillus sp. S7-16. The optimal composition of the medium for the production of fibrinolytic enzyme by Bacillus sp. S7-16 was 0.5%(w/v) polypeptone, 0.5%(w/v) yeast extract, 0.3%(w/v) NaCl, 0.1% (w/v) $KH_2PO_4,\;0.3%(w/v)\;K_2PHO_4,\;and\;0.01%(w/v)\;MgSO_4{\cdot}7H_2O$. The optimal temperature and initial pH of the medium for the production of the enzyme were $35^{\circ}C$ and 7.0, respectively. The maximum production of the fibrinolytic enzyme was obtained after 24 hours of the incubation. Under the above conditions, the culture supernatant had strong fibrinolytic activity. Within pH4~11, the crude fibrinolytic enzyme was stable. The enzyme was stable up to $50^{\circ}C$. The optimum pH and temperature for the enzyme activity were around 7.5 and $40^{\circ}C$, respectively.

키워드

참고문헌

  1. Thromb. Res. v.52 no.6 A directacting fibrinolytic enzyme from the venom of Agkistrodon contortrix: effects on various components of the human blood coagulation and fibrinolisis systems Retzios, A. D.;Markland, F. S. Jr.
  2. Japanese J. Phys. v.41 no.3 A novel fibrinolytic enzyme extracted from the earthworm, Lumbricus rubellus. Mihara, H.;Sumi, H.;Yoneta, T.;Mizumoto, H.;Ikeda, R.;Seiki, M.;Maruyama, M.
  3. Biosci. Biotech. Biochiem. v.57 no.10 Characterization of potent fibrinolytic enzymes in earthworm, Lumbricus rubellus. Nakajima, N.;Mihara, H.;Sumi, H.
  4. Zentrai. fur Mikrobiol. v.148 no.2 Production and some properties of fibrinolytic enzymes from Fusarium oxysporun N.R.C.1. Abdel-Fattah, A. F.;Ismail, A. M.;Saleh, S. A.
  5. Zeit. fur Ernahrung. v.19 no.1 Fibrinolytic activity of an enzyme produced by Bacillus subtilis. Fayek, K. I.;El-Sayed. S. T.
  6. Zeit fur Allgem. Mikrobiol. v.20 no.6 Purification and properties of a fibrinolytic enzyme from Bacillus subtilis. Fayek, K. I.;El-Sayed. S. T.
  7. Experientia v.43 A nobel fibrinolytic enzyme(nattokinase) in the vegetable cheese Natto; a typical and popular soybean food in the Japanese Diet. Sumi, H.;Hamada, H.;Tsushima, H.;Mihara, H.;Muraki, H.
  8. Kor. J. Appl. Microbiol. Biotechnol. v.23 no.1 청국장으로부터 혈전용해균 주의 분리 및 동정 김용택;김원극;오훈일
  9. Biochem. Biophys. ACTA. v.61 Urokinase an activator from human urine, I. Isolation and properties. Plug, J.;Kjeldgarrd, O.
  10. J. Clin. Ivest. v.75 Transport of urokinase across the intestinal tract of normal Uman Subjects with stimulation of synthesis and/or release of urokinase-type proteins. Toki, N.;Sumi, H.;Sasaki, K.;Boreisha, I.;Robbins, K. C.
  11. Pro. Soc. Exp. Bio. Med. v.94 Methods employed for purification of streptokinase Fletcher, A. P.;Johnson, A. J.
  12. Biochim. Biophys. ACTA. v.144 Interaction of staphylokinase with different molecular forms of plasminogen. Lijnen, H. R.;van Hoef;Coolen, D.
  13. ACTA Physiol. Scand. v.36 The plasminogen activator in animal tissue. Astrup. T.;Stermdorff, I.
  14. Bergey's mannual of systematic bacteriology v.2 Murray, R. G. E.(et al.)
  15. 미생물과 산업 v.22 no.2 Streptokinase의 생산에 관한 연구 이인애;이홍수;성창근;최인성;민태익;정태화;최용경
  16. Enzyme v.33 Plasmid fibrinolysis after intraduodenal administration of urokinase in rats. Sumi, H .;Seiki, M.;Morimoto, N.;Tshushima, H.;Maruyama, M.;Mihara, H.
  17. Thromb. Res. v.20 Oral administration of urolinase. Sumi, H.;Sasaki, K.;Toki, N.;Robbins, K. C.